sero-prevalence studies

treatment

Article in BMC Public Health 2011, 11:700. Background Concerns have been raised that marginalised populations may not achieve adequate compliance to antiretroviral therapy. Our objective was to describe the long-term virological, immunological and mortality outcomes of providing highly active antiretroviral therapy (HAART) with strong adherence support to HIV-infected female sex workers (FSWs) in Burkina Faso and contrast outcomes with those obtained in a cohort of regular HIV-infected women. Article in the Lancet, Volume 377, Issue 9779, Page 1719, 21 May 2011. This article gives more detail on the recent trial of HIV treatment as a form of HIV prevention. The

Cambodia

This news story, by Noy Thrupkaew in The Nation, explores approaches to combatting trafficking with particular reference to the work of the International Justice Mission. This document is published by the Global Campaign for Microbicides and is based on interviews conducted in Cambodia and by telephone from mid-2006 through 2008 with key players in the events surrounding the 2004 trial to determine whether tenofovir disoproxil fumarate was safe and effective for use as a pre-exposure chemoprophylaxis to prevent HIV transmission. Before the trial formally began, preparations for it were halted by the Cambodian government following protests led by the Women’s

new technologies

An HIV and AIDS Reporter from Eldis authored by Hawkins K and Overs C. This guide to recent research touches upon some potential new directions in policy and programming including new prevention technologies and economic empowerment programming. STELLA is a Canadian sex worker group that has developed its own code of research ethics for clinical trials on new HIV-prevention and treatment technologies or sero-prevalence studies.

treatment

Cambodia

new technologies

Keyword search